Cargando…

Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients

Detalles Bibliográficos
Autores principales:	Aleman, Adolfo, Van Oekelen, Oliver, Upadhyaya, Bhaskar, Beach, Katherine, Kogan Zajdman, Ariel, Alshammary, Hala, Serebryakova, Kseniya, Agte, Sarita, Kappes, Katerina, Gleason, Charles R., Srivastava, Komal, Almo, Steve, Cordon-Cardo, Carlos, Krammer, Florian, Merad, Miriam, Jagannath, Sundar, Wajnberg, Ania, Simon, Viviana, Parekh, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983835/ https://www.ncbi.nlm.nih.gov/pubmed/35390296 http://dx.doi.org/10.1016/j.ccell.2022.03.013

Ejemplares similares

Cellular Immune Composition in Multiple Myeloma Patients Associated with Variable Humoral Responses to Sars-Cov-2 Vaccination
por: Kogan Zajdman, Ariel, et al.
Publicado: (2022)

OAB-048: Suboptimal humoral immune response to SARS-CoV-2 mRNA vaccination in myeloma patients is associated with anti-CD38 mAb and BCMA-targeted treatment
por: Oekelen, Oliver Van, et al.
Publicado: (2021)

Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma
por: Aleman, Adolfo, et al.
Publicado: (2021)

NP-114: Lesson Learned: Management of patients with Multiple Myeloma (MM) and their response to two doses of COVID-19 RNA vaccine
por: Verina, Daniel, et al.
Publicado: (2021)

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
por: Van Oekelen, Oliver, et al.
Publicado: (2021)

Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment
por: Van Oekelen, Oliver, et al.
Publicado: (2021)

Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
por: Elnaggar, Muhammad, et al.
Publicado: (2022)

Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
por: Elnaggar, Muhammad, et al.
Publicado: (2023)

MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward
por: Wang, Bo, et al.
Publicado: (2020)

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
por: Mouhieddine, Tarek H., et al.
Publicado: (2022)

SARS-CoV-2 viral load predicts COVID-19 mortality
por: Pujadas, Elisabet, et al.
Publicado: (2020)

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
por: Wang, Bo, et al.
Publicado: (2020)

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
por: Wang, Bo, et al.
Publicado: (2020)

CD8(+) T cells: An ineffective armor against prolonged COVID-19 in cancer patients
por: Van Oekelen, Oliver, et al.
Publicado: (2022)

Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
por: Singh, Gagandeep, et al.
Publicado: (2023)

At the Crossroads of Inflammation and Tumorigenesis
por: Cordon-Cardo, Carlos, et al.
Publicado: (1999)

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

Applications of array technology: identification of molecular targets in bladder cancer
por: Sánchez-Carbayo, M, et al.
Publicado: (2003)

COVID-19: Staging of a New Disease
por: Cordon-Cardo, Carlos, et al.
Publicado: (2020)

Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study
por: Wajnberg, Ania, et al.
Publicado: (2020)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

Demographic Characteristics of Adults with IgG Antibodies to Prior Symptomatic SARS-CoV-2 Infection
por: Mansour, Mayce, et al.
Publicado: (2021)

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
por: Krammer, Florian, et al.
Publicado: (2021)

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
por: Mohr, Lisa, et al.
Publicado: (2017)

Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City
por: Mansour, Mayce, et al.
Publicado: (2020)

Identifying Sociodemographic Characteristics Associated With Burden Among Caregivers of the Urban Homebound: The Importance of Racial and Relationship Differences
por: Wajnberg, Ania, et al.
Publicado: (2016)

Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008
por: Jagannath, Sundar
Publicado: (2009)

P876: INCIDENTAL DISCOVERY OF PROBABLE PATHOGENIC GERMLINE VARIANTS IN MULTIPLE MYELOMA PATIENTS UNDERGOING SOMATIC GENOMIC PROFILING
por: Thibaud, S., et al.
Publicado: (2022)

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
por: Han, Dan, et al.
Publicado: (2019)

The success of behavioral economics in improving patient retention within an intensive primary care practice
por: Groden, Phillip, et al.
Publicado: (2021)

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
por: Lancman, Guido, et al.
Publicado: (2018)

Association of micronutrient status with subclinical health complaints in lactovegetarian adults
por: Chiplonkar, Shashi Ajit, et al.
Publicado: (2007)

Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
por: Chae, Young Kwang, et al.
Publicado: (2018)

Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma
por: Chae, Young Kwang, et al.
Publicado: (2019)

Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
por: Bhalla, Sherry, et al.
Publicado: (2021)

Implementation Science Workshop: a Novel Multidisciplinary Primary Care Program to Improve Care and Outcomes for Super-Utilizers
por: Lynch, Colleen S., et al.
Publicado: (2016)

A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
por: Kimmerling, Robert J., et al.
Publicado: (2022)

Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
por: Kimmerling, Robert J., et al.
Publicado: (2023)

Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression
por: Rego, Eduardo M., et al.
Publicado: (2001)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrkm1ts1hl76vdi791mvm0k73d